MedPath

Eye & ENT Hospital of Fudan University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Vision Therapy Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia

Not Applicable
Recruiting
Conditions
Esotropia
Interventions
Other: Vision therapy group
Other: Prism
First Posted Date
2024-10-01
Last Posted Date
2024-12-04
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
100
Registration Number
NCT06622044
Locations
🇨🇳

Eye & ENT Hospital of Fudan University, Shanghai, China

Foldable Capsular Scleral Buckling Versus Vitrectomy in Medium-complex Rhegmatogenous Retinal Detachment Treatment

Not Applicable
Not yet recruiting
Conditions
Rhegmatogenous Retinal Detachment
Interventions
Procedure: foldable capsular scleral buckling
Procedure: vitrectomy
First Posted Date
2024-09-24
Last Posted Date
2024-09-24
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
100
Registration Number
NCT06610786
Locations
🇨🇳

EyeEntFudan, Shanghai, Shanghai, China

Application and Effectiveness of the Perioperative Position Management Based on the ADDIE Model in Patients With Congenital Microtia

Not Applicable
Completed
Conditions
Congenital Microtia
Interventions
Procedure: Utilization of a perioperative position management protocol for congenital microtia patients based on the ADDIE model.
First Posted Date
2024-08-26
Last Posted Date
2024-08-26
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
196
Registration Number
NCT06569927
Locations
🇨🇳

Eye & ENT Hospital, Fudan University, Shanghai, Shanghai, China

The Application of Photosensitive Hydrogel in Intranasal Endoscopic Dacryocystorhinostomy

Not Applicable
Recruiting
Conditions
Chronic Dacryocystitis
Interventions
Device: 6-0 absorbable stitches
Device: Photosensitive hydrogel
First Posted Date
2024-08-13
Last Posted Date
2024-08-13
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
20
Registration Number
NCT06551766
Locations
🇨🇳

Eye & ENT Hospital of Fudan University, Shanghai, China

AR Training Versus Patching in Unilateral Amblyopia

Not Applicable
Recruiting
Conditions
Amblyopia Unilateral
Interventions
Other: AR training
Other: Patching
First Posted Date
2024-07-12
Last Posted Date
2025-04-10
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
114
Registration Number
NCT06498206
Locations
🇨🇳

Eye & ENT Hospital of Fudan University, Shanghai, China

Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis

Early Phase 1
Recruiting
Conditions
Bacterial Keratitis
Antibiotic-resistant Bacteria
Infections, Bacterial
Corneal Diseases
Eye Diseases
Vision Disorders
Sensation Disorders
Blindness
Antisense Peptide Nucleic Acid
Antibacterial Therapy
Interventions
Drug: ASO
First Posted Date
2024-06-11
Last Posted Date
2024-06-11
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
20
Registration Number
NCT06451172
Locations
🇨🇳

Eye & ENT Hospital of Fudan University, Shanghai, Shanghai, China

Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma

Early Phase 1
Recruiting
Conditions
Retinoblastoma
Refractory
Interventions
Drug: Targeting NUDT21 siRNA drugs
First Posted Date
2024-05-22
Last Posted Date
2025-04-08
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
20
Registration Number
NCT06424301
Locations
🇨🇳

Fudan Eye & ENT Hospital, Shanghai, China

A Comparative Analysis of Speech Perception Between Cochlear Implant Patients and DFNB9 Patients Receiving Gene Therapy

Recruiting
Conditions
Hearing Loss
Genetic Disease
Speech Perception
First Posted Date
2024-02-01
Last Posted Date
2025-02-05
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
80
Registration Number
NCT06237790
Locations
🇨🇳

Eye & ENT Hospital of Fudan University, Shanghai, Shanghai, China

Neoadjuvant Vs Adjuvant in Locally Advanced Recurrent NPC

Phase 3
Recruiting
Conditions
Recurrent Nasopharyngeal Carcinoma
Interventions
Procedure: endoscopic surgery
Drug: Adjuvant therapy in control group,Toripalimab Injection and Gemcitabine based therapy
Drug: Neoadjuvant therapy,Toripalimab Injection and Gemcitabine based therapy
Drug: Adjuvant therapy in experimental group,Toripalimab Injection and Gemcitabine based therapy
First Posted Date
2024-01-31
Last Posted Date
2024-12-31
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
154
Registration Number
NCT06235203
Locations
🇨🇳

Eye& ENT Hospital, Fudan University, Shanghai, Shanghai, China

🇨🇳

Fujian Medical University Union Hospital, Fuzhou, China

🇨🇳

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China

and more 4 locations

Adjuvant Vs Surgery Only in Early-stage Recurrent NPC

Phase 3
Recruiting
Conditions
Recurrent Nasopharyngeal Carcinoma
Interventions
Drug: Immunotherapy,Toripalimab Injection
Drug: Chemotherapy,Gemcitabine based regimen
First Posted Date
2024-01-29
Last Posted Date
2024-12-31
Lead Sponsor
Eye & ENT Hospital of Fudan University
Target Recruit Count
176
Registration Number
NCT06228079
Locations
🇨🇳

Eye& ENT Hospital, Fudan University, Shanghai, Shanghai, China

🇨🇳

Fujian Medical University Union Hospital, Fuzhou, China

🇨🇳

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath